The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma
Sha Zeng(Integrated Chinese Medicine (China)), Shuichi Kaneko(Kanazawa University)
Cited by 143
Related Papers
The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter study
|Hepatology Research|2008|142
No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations
|BMC Medical Genetics|2012|41
Peretinoin, an acyclic retinoid, inhibits hepatocarcinogenesis by suppressing sphingosine kinase 1 expression in vitro and in vivo
|Scientific Reports|2017|35
Sorafenib suppresses extrahepatic metastasis de novo in hepatocellular carcinoma through inhibition of mesenchymal cancer stem cells characterized by the expression of CD90
|Scientific Reports|2017|34
BMP9‐ID1 signaling promotes EpCAM‐positive cancer stem cell properties in hepatocellular carcinoma
|Molecular Oncology|2021|29